Genelux Corporation (GNLX)
NASDAQ: GNLX · Real-Time Price · USD
3.200
+0.010 (0.31%)
Aug 13, 2025, 4:00 PM - Market closed
Genelux Market Cap
Genelux has a market cap or net worth of $119.49 million as of August 14, 2025. Its market cap has increased by 58.11% in one year.
Market Cap
119.49M
Enterprise Value
93.22M
1-Year Change
58.11%
Ranking
Category
Stock Price
$3.20
Market Cap Chart
Since the IPO on January 26, 2023, Genelux's market cap has decreased from $141.69M to $119.49M, a decrease of -15.67%. That is a compound annual growth rate of -6.47%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Aug 13, 2025 | 119.49M | 48.46% |
| Dec 31, 2024 | 80.49M | -78.50% |
| Dec 29, 2023 | 374.31M | 164.17% |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Eli Lilly and Company | 592.95B |
| Johnson & Johnson | 420.06B |
| AbbVie | 355.91B |
| UnitedHealth Group | 246.17B |
| AstraZeneca | 240.81B |
| Novartis AG | 234.72B |
| Novo Nordisk | 227.37B |
| Abbott Laboratories | 225.22B |